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Effect of Hyperthermia on Prognosis After Acute
Ischemic Stroke
Monica Saini, MD; Maher Saqqur, FRCPC; Anmmd Kamruzzaman, MSc; Kennedy R. Lees, MD, FRCP;
Ashfaq Shuaib, FRCPC; on behalf of the VISTA Investigators
Background and Purpose—Experimental studies have shown that hyperthermia is a determinant of poor outcome after
ischemic stroke. Clinical studies evaluating the effect of temperature on poststroke outcome have, however, been limited
by small sample sizes. We sought to evaluate the effect of temperature and timing of hyperthermia on outcome after
ischemic stroke.
Methods—Data of 5305 patients in acute stroke trials from the Virtual International Stroke Trials Archive (VISTA) data
set were analyzed. Data for temperatures at baseline, eighth, 24th, 48th, and 72nd hours, and seventh day were assessed
in relation to outcome (poor versus good) based on the modified Rankin Scale at 3 months. Hyperthermia was defined
as temperature 37.2°C and poor outcome as 90-day modified Rankin Scale 2. Hazard ratios with 95% CIs were
reported for hyperthermia in relation to the outcome. Logistic regression models, in relation to hyperthermia, were fitted
for a set of preselected covariates at different time points to identify predictors/determinants of hyperthermia.
Results—The average age of patients was 68.011.9 years, 2380 (44.9%) were females, and 42.3% (2233) received
thrombolysis using recombinant tissue plasminogen activator. After adjustment, hyperthermia was a statistically
significant predictor of poor outcome. The hazard ratios (95% CI) for poor outcome in relation to hyperthermia at
different time points were: baseline 1.2 (1.0 to 1.4), eighth hour 1.7 (1.2 to 2.2), 24th hour 1.5 (1.2 to 1.9), 48th hour
2.0 (1.5 to 2.6), 72nd hour 2.2 (1.7 to 2.9), and seventh day 2.7 (2.0 to 3.8). Gender, stroke severity (National Institutes
of Health Stroke Scale score 16), white blood cell count, and antibiotic use were significantly associated with
hyperthermia (P0.01).
Conclusions—Hyperthermia, in acute ischemic stroke, is associated with a poor clinical outcome. The later the
hyperthermia occurs within the first week, the worse the prognosis. Severity of stroke and inflammation are important
determinants of hyperthermia after ischemic stroke. In patients with acute ischemic stroke, aggressive measures to
prevent and treat hyperthermia could improve the clinical outcomes. (Stroke. 2009;40:3051-3059.)
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Stroke remains one of the leading causes of mortality andmorbidity worldwide. Poststroke disability and handicap
have a significant physical and economic impact.1,2 Recom-
binant tissue plasminogen activator (rtPA) remains the only
agent that has proven clinical efficacy in improving outcomes
after ischemic stroke; however, only 5% of patients receive
rtPA due to various reasons.3 Attempts to find neuroprotec-
tive agents that may reduce ischemic brain damage have been
unrewarding to date.4 Identification of potentially modifiable
factors that determine recovery and functional outcomes after
stroke are thus essential for minimization of poststroke
deficits.
Several factors determine the outcome and extent of
recovery after ischemic stroke. Data from preclinical studies
provided a link between hyperthermia and stroke outcomes,
and robust experimental evidence for detrimental effects of
hyperthermia on ischemic brain injury is available.5–7 Fever
(temperature 38°C) has been included as an independent
prognostic marker in validated prognostic models for predic-
tion of mortality and functional outcome after an acute
ischemic stroke.8,9 A recent meta-analysis suggested that
pyrexia after stroke was significantly associated with mortal-
ity and morbidity. This analysis included patients with both
ischemic and hemorrhagic stroke.10 A few clinical studies
have evaluated body temperature in relation to type, location,
severity, and mechanism of stroke.11–13 The Copenhagen
Stroke Study group showed that body temperature was an
independent predictor of good functional outcome after
stroke; a 1°C decrease in temperature corresponded to almost
doubling (OR, 1.8) the chance of a good outcome.11 Simi-
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larly, Reith et al showed that the relative risk of poor outcome
increased by 2.2 times for each 1°C increase in body
temperature.12 Although the relation of timing of hyperther-
mia in relation to stroke outcome has been evaluated previ-
ously, the relation is not clear.13
Previous studies evaluating the effect of temperature have
been limited by small numbers of patients and have used
temperatures recorded at diverse times from stroke onset.
Also, a range of definitions of hyperthermia was used in the
studies included in the analysis, which may have a bearing on
the results. We sought to determine the effect of temperature,
in relation to time, on outcome after ischemic stroke using
data from the Virtual International Stroke Trials Archive
(VISTA).
Methods
Data were obtained for patients with acute ischemic stroke from the
VISTA database. Details of the VISTA collaboration have been
previously published; the database includes data from trials that had
documented entry criteria and monitoring processes for validation of
data.14 VISTA holds data from 28 trials involving more than 28 000
patients, aged between 18 and 103 years, who experienced an index
acute stroke due to either ischemia or intracerebral hemorrhage. Data
have been collected prospectively and include demographic charac-
teristics, baseline neurological assessment, and 90-day Barthel Index
modified Rankin Scale (mRS), and National Institutes of Health
Stroke Scale (NIHSS).
VISTA regulations preclude the identification of trial source(s);
however, for the purpose of our analysis, data were extracted for
patients with ischemic stroke with records of body temperatures at
various time intervals after the index event. The diagnosis of
ischemic stroke was confirmed by imaging (CT/MRI) in all patients.
Demographic details and medical history, including diabetes, hyper-
tension, prior stroke, myocardial infarction (MI), and baseline stroke
severity, as determined by NIHSS, have been recorded for all
patients.
Temperature Measurement
In most patients, the method of temperature measurement was an
axillary recording. It was assumed that normal diurnal variation of
body temperature is 1°C. Data from a recent review, on normal
body temperature in adults, were used for defining hyperthermia.15
Hyperthermia was defined as temperature 37.2°C.
Values for body temperature at baseline and thereafter at 8, 24, 48,
72 hours and 7 days were extracted from the database. For deter-
mining the effect of temperature on the outcome, temperature was
dichotomized to normothermia (37.2°C) versus hyperthermia
(37.2°C). To further analyze the effect of temperature on out-
comes, temperature differences were calculated at various time
points with reference to the baseline temperature. Body temperature
was further categorized as quartiles (36.4, 36.4 to36.78, 36.78 to
37.1, and 37.1°C). The highest quartile (37.1°C) was taken as
the reference.
Stroke Topography and Severity
The side of hemispheric involvement (right versus left) was recorded
for patients based on imaging (CT/MRI). Stroke severity was
determined using the NIHSS at baseline and at 24 hours. Stroke was
classified as severe (NIHSS 16) and mild to moderate (NIHSS
16). To further analyze the relation of stroke severity and hyper-
thermia at various time points, the 24-hour NIHSS was categorized
into 3 groups: 0 to 10, 10 to 20, and 20. Lesion volume was
measured on CT/ MRI between 24 hours and 7 days of onset of ictus.
Inflammation and Infection
White blood cell (WBC) and platelet count were used as markers of
inflammation. These were classified as normal (WBC11 000/mm3
and platelet 230/mm3) and abnormal (WBC 11 000/mm3 and
platelet 230/mm3). The use of antibiotics was considered as a
surrogate marker for infection.
Clinical Outcome Measurement
The long-term clinical outcome was measured at 3 months (90 days)
using mRS. Functional outcome was dichotomized, poor versus
good, based on the mRS at 3 months. Poor outcome was defined as
mRS 2. Poststroke mortality up to 90 days was measured. For
patients who died during this time period, the mRS was defined as 6
for the analysis.
Statistical Analysis
Demographic statistics (number of patients, mean, SD, median, and
interquartile range) of the study patients with an acute ischemic
stroke were summarized. Univariate analyses for demographic vari-
ables (age and gender), temperatures (at baseline, 24th hour, 48th
hour, 72nd hour, and seventh day), baseline NIHSS, and other
potential covariates (MI, hypertension, diabetes, smoking status, and
rtPA) by outcome variable (“good” versus “poor”) were performed.
Probability values were computed to compare “good versus poor”
outcome. To quantify model’s ability to discriminate between
“good” outcome versus “poor” outcome, we computed the area
under the receiver operating characteristic curve. Usually, a model
having area under the receiver operating characteristic curve 0.8
has some ability in predicting the responses of individual subjects.
Also, we used the area under the receiver operating characteristic
curve to evaluate the cutoff for body temperature, which eventually
categorized patients into hyperthermia and nonhyperthermia. To
assess the relation between outcome variable and temperature at
specific times (baseline, eighth hour, 24th hour, 48th hour, 72nd
hour, or seventh day), simple and multivariable logistic regression
analysis were performed. Unadjusted and adjusted ORs with 95%
CIs were reported. Adjustments were made for age, gender, MI,
hypertension, diabetes, rtPA, smoking status, and baseline NIHSS.
We carried out Kaplan-Meier survival analysis to perceive the
change in survival for patients with hyperthermia versus patients
without hyperthermia with temperatures over time. To evaluate how
survival was influenced by temperature over time, both univariable
and multivariable analyses were performed using Cox proportional
hazard models. Unadjusted and adjusted hazard ratios with 95% CIs
were reported. Similar to adjusted ORs, adjusted hazard ratios
associated with temperature were computed after taking account the
effects of age, gender, MI, hypertension, diabetes, rtPA, smoking
status, and baseline NIHSS.
To identify for predictors/determinants of hyperthermia, logistic
regression models in relation to hyperthermia are fitted for a set of
preselected covariates at different time points. The preselected
covariates are patients’ age, gender (male/female), smoking status
(nonsmoker/current-smoker/exsmoker), congestive heart failure
(yes/no), atrial fibrillation (yes/no), NIHSS at baseline, NIHSS at the
24th hour (16,16), hemispheric stroke (right/left), lesion volume
(0 to 110,110 mm3), rtPA use (yes/no), antibiotic use (yes/no), and
WBC count (0 to 11, 11 in 103/mm3). The covariate, lesion
volume, is categorized using the average lesion volume (approxi-
mately 110 mm3) in the nonhyperthermia patients. We have per-
formed this analysis for patients whose body temperatures are
available at or after the 24th hour because one of our covariates of
interest is NIHSS at the 24th hour. All of the analyses were executed
in SAS (Version 9.1.3).
Results
Data were extracted for 5305 patients with an acute ischemic
stroke. The average age of patients was 68.011.9 years and
2380 (44.9%) were females. Baseline characteristics of the
patients are summarized in Table 1 . Temperature measure-
ments were available for the following number of patients:
5128 (96.3%) at baseline, 1702 (31.9%) at the eighth hour,
3058 (56.7%) at the 24th hour, 1688 (31.6%) at the 48th hour,
1829 (34.3%) at the 72nd hour, and 1631 (30.6%) at the
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seventh day. The absolute difference in baseline temperatures
between patients with missing and available follow-up tem-
perature recordings was 0.35°C, 0.19°C, 0.33°C, 0.30°C, and
0.33°C at the eighth hour, 24th hour, 48th hour, 72nd hour,
and seventh day, respectively (P0.01). Patients with miss-
ing data at follow-up had lower baseline temperatures. A total
of 976 (18.2%) of the study patients died within 1 week from
baseline.
Hyperthermia (temperature 37.2°C) was recorded in
15.9% (n817), 11.0% (n188), 17.2% (n521), 19.1%
(n323), 17.9% (n328), and 9.3% (n152) of the study
patients at baseline, eighth hour, 24th hour, 48th hour, 72nd
hour, and seventh day, respectively. Any increase in temper-
ature, as compared with baseline, was seen in 26.4% patients
at the eighth hour and 39.5% of patients at the 24th hour after
the index event. A greater than 1°C increase in temperature
was seen in 3.0% patients at the eighth hour and 5.6% patients
at the 24th hour.
Characteristics of the study patients by outcome variable
(univariate analysis) are summarized (Table 2). Older patients
(70 years), females, and patients with MI and diabetes were
more likely to have a poor outcome. There were statistically
significant associations between temperature and poor out-
come (P0.0001) at baseline, eighth hour, 24th hour, 48th
hour, 72nd hour, and seventh day. Unadjusted and unadjusted
ORs with 95% CIs of preselected covariates (risk factors) are
provided in Table 3. Based on the multivariate analysis, age
(P0.001), baseline NIHSS (P0.001), intravenous rtPA
administration (P0.001), and temperatures at the eighth
hour (P0.01), 48th hour (P0.01), 72nd hour (P0.001),
and seventh day (P0.001) appeared to be statistically
significant predictors of a poor long-term outcome of patients
with an acute ischemic stoke (Table 3). The areas under the
receiver operating characteristic curve of the models with the
mentioned time points were consistently 0.8. It indicates
models’ ability to discriminate subjects into poor versus good
outcome as well as high sensitivity and specificity of the body
temperature cutoff we used to define hyperthermia.
A total of 996 (18.8%) patients died during the 3-month
follow-up period. Kaplan-Meier survival curves at various
time points for hyperthermia are shown in Figure 1. No
significant difference was observed in the mortality rate
between patients with hyperthermia versus normothermia at
baseline (P0.68). However, compared with normothermic
patients, the mortality rates were significantly higher
(P0.001) in the patients with hyperthermia at and after the
eighth hour (Figure 1).
After adjusting for age, gender, hypertension, diabetes, MI,
smoking status, baseline NIHSS, and intravenous rtPA ad-
Table 1. Demographics of Study Patients With an Acute
Ischemic Stoke (n5305)
Variable Statistics
Age, years, mean (SD) 68.0 (11.9)
Females, n (%) 2380 (44.9)
Atrial fibrillation, n (%) 1367 (25.8)
MI, n (%) 569 (10.7)
Previous transient ischemic attack or stroke, n (%) 454 (8.6)
Diabetes, n (%) 1181 (22.3)
Hypertension, n (%) 3704 (69.8)
Baseline NIHSS, median (IQ range) 12 (8–18)
Received rtPA, n (%) 2233 (42.1)
mRS at 90 days, median (IQ range) 3 (1–5)
Barthel Index 90 days, median (IQ range) 90 (55–100)
Smoking status, n (%) 758 (14.3)
Mortality within 90 days, n ( %) 880 (16.6)
Temperature, °C, median (IQ range)
At baseline 36.8 (36.4–37.1)
At eighth hour 36.7 (36.4–36.9)
At 24th hour 36.7 (36.5–37.1)
At 48th hour 36.7 (36.5–37.1)
At 72nd hour 36.7 (36.5–37.1)
At seventh day 36.6 (36.4–36.8)
IQ indicates interquartile.
Table 2. Characteristics of Study Patients by ‘Good’ versus
‘Poor ’ Outcome
Good (mRS 2) Poor (mRS 2)
Variable (n2209) (n3096) P Value
Age, years, mean (SD) 64.8 (12.0) 70.3 (11.3) 0.001
Age category, n (%)
70 years 1375 (50.2) 1366 (49.8) 0.001
70 years and older 834 (32.5) 1730 (67.5)
Baseline NIHSS, mean (SD) 8.9 (4.9) 16.0 (6.4) 0.001
Gender, n (%)
Male 1301 (44.5) 1624 (55.5) 0.001
Female 908 (38.2) 1472 (61.8)
MI, n (%)
Yes 205 (36.0) 364 (64.0) 0.01
No 2004 (42.3) 2732 (57.7)
Hypertension, n (%)
Yes 1504 (40.6) 2200 (59.4) 0.02
No 705 (44.0) 896 (56.0)
Diabetes, n (%)
Yes 429 (36.3) 752 (63.7) 0.001
No 1780 (43.2) 2344 (56.8)
rtPA, n (%)
Yes 999 (44.7) 1234 (55.3) 0.001
No 1210 (39.4) 1862 (60.6)
Smoking status
Yes 384 (50.7) 374 (49.3) 0.001
No 1825 (40.1) 2722 (59.9)
Temperature, °C, mean (SD)
At baseline 36.81 (0.5) 36.84 (0.6) 0.001
At eighth hour 36.63 (0.4) 36.76 (0.5) 0.001
At 24th hour 36.71 (0.5) 36.82 (0.6) 0.001
At 48th hour 36.62 (0.5) 36.81 (0.6) 0.001
At 72nd hour 36.66 (0.5) 36.93 (0.7) 0.001
At seventh day 36.52 (0.4) 36.64 (0.6) 0.001
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ministration, in the Cox proportion hazard model, hyperther-
mia appeared as a statistically significant predictor of poor
outcome. The hazard ratios (95% CI) for temperatures at
different time points were: baseline 1.2 (1.0 to 1.4), eighth
hour 1.7 (1.2 to 2.2), 24th hour 1.5 (1.2 to 1.9), 48th hour 2.0
(1.5 to 2.6), 72nd hour 2.2 (1.7 to 2.9), and seventh day 2.7
(2.0 to 3.8). The likelihood of a poor outcome appeared to be
greater the later the hyperthermia. In addition, any increase in
temperature, with relation to the baseline, was a significant
predictor of poor outcome. The hazard ratios for poor
Table 3. Unadjusted and Adjusted ORs for Potential Covariates and Temperature at Specific
Time Point (baseline, eighth hour, 24th hour, 48th hour, 72nd hour, or seventh day) in Relation
to ‘Poor ’ Long-Term Outcome (mRS >2)
Univariate Analysis Multivariable Analysis*
Variable OR (95% CI) P Value OR (95% CI) P Value
Gender
Female 1.0 1.0
Male 1.3 (1.2–1.5) 0.001 1.1 (1.0–1.3) 0.10
Age
70 years 1.00 1.0
70 years 2.1 (1.9–2.3) 0.001 2.2 (1.9–2.5) 0.001
MI
No 1.00 1.0
Yes 1.3 (1.1–1.6) 0.01 1.0 (0.8–1.3) 0.99
Hypertension
No 1.00 1.0
Yes 1.2 (1.0–1.3) 0.02 1.1 (0.9–1.3) 0.25
Diabetes
No 1.00 1.0
Yes 1.3 (1.2–1.5) 0.001 1.2 (1.0–1.4) 0.10
rtPA
Yes 1.00 1.0
No 1.2 (1.1–1.4) 0.001 1.8 (1.5–2.0) 0.001
Smoking status
No 1.00 1.0
Yes 1.5 (1.3–1.8) 0.001 1.2 (1.0–1.5) 0.05
Baseline NIHSS 1.3 (1.2–1.3) 0.001 1.3 (1.2–1.3) 0.001
Temperature at baseline, °C
37.2 1.00 1.0
37.2 0.8 (0.7–0.9) 0.001 0.9 (0.7–1.1) 0.27
Temperature at eighth hour, °C
37.2 1.00 1.0
37.2 2.5 (1.8–3.6) 0.001 1.9 (1.3–2.7) 0.01
Temperature at 24th hour, °C
37.2 1.00 1.0
37.2 1.7 (1.4–2.1) 0.001 1.2 (1.0–1.6) 0.10
Temperature at 48th hour, °C
37.2 1.00 1.0
37.2 3.0 (2.3–3.9) 0.001 1.7 (1.2–2.3) 0.01
Temperature at 72nd hour, °C
37.2 1.00 1.0
37.2 4.3 (3.2–5.9) 0.001 2.7 (1.9–3.8) 0.001
Temperature at seventh day, °C
37.2 1.00 1.0
37.2 5.7 (3.6–9.1) 0.001 4.5 (2.7–7.5) 0.001
*Temperatures at baseline, eighth hour, 24th hour, 48th hour, 72nd hour, and seventh day are adjusted for gender,
age, MI, hypertension, diabetes, rtPA, smoking status, and baseline NIHSS separately.
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outcome (95% CI), for patients in whom a rise in temperature
was recorded, were: 1.5 (1.2 to 1.9) at the eighth hour, 1.5
(1.2 to 1.8) at the 24th hour, 2.1 (1.6 to 2.7) at the 72nd hour,
and 2.4 (1.8 to 3.1) at seventh day. The baseline body
temperature was categorized as quartiles (36.4°C, 36.4°C to
36.78°C, 36.78°C to37.1°C, and37.1°C). After adjust-
ing for gender, age, MI, hypertension, diabetes, rtPA, smok-
ing status, and baseline NIHSS, no overall significant differ-
ence was observed between quartiles (P0.66) and even at
individual quartile level in relation to poor long-term
outcome.
Further analysis was performed to determine predictors of
hyperthermia. Univariate analysis for variables in relation to
hyperthermia at 24 hours showed no significant difference in
age and prevalence of hypertension, diabetes, and MI be-
tween patients with and without hyperthermia (P0.5). A
total of 20.8% (n273) females and 14.1% (n248) males
had hyperthermia at 24 hours (P0.001). Nonsmokers/exs-
mokers and patients with atrial fibrillation and congestive
heart failure were more likely to have hyperthermia
(P0.001). The mean NIHSS was 13.9 (7.6) and 14.7
(7.8) in patients with hyperthermia versus 12 (7.2) and
8.9 (6.2) in nonhyperthermic patients at baseline and 24
hours, respectively (P0.001). Hyperthermia (at 24 hours)
was recorded in 36.8% (n127) patients with 24 hour NIHSS
16 compared with 14.3% (n195) of patients with 24-hour
NIHSS 16 (P0.001). Patients with hyperthermia were
more likely to have abnormal WBC counts compared with
patients without hyperthermia (58.4% versus 43.9%;
P0.001); however, no significant difference was seen in
platelet counts in the 2 groups (P0.33). Among patients
who were thrombolyzed, 18.8% (195 of 1034) had hyperther-
mia compared with 16.1% (326 of 2024) in the nonthrombo-
lyzed patients (P0.05). Antibiotics were used in 48.1% (225
of 467) of patients with hyperthermia and 33% (769 of 2329)
of nonhyperthermic patients (P0.001).
The results of the multivariate analysis, for hyperthermia at
24 hours and 7 days and the adjusted OR are summarized in
Table 4. Female gender (OR, 1.58), presence of atrial
fibrillation (OR, 1.39), left hemispheric stroke (OR, 1.25) and
severe stroke (24-hour NIHSS16; OR, 2.76) were indepen-
dent predictors of hyperthermia at 24 hours. Severe stroke
(NIHSS 16) and presence of congestive heart failure
showed significant association with hyperthermia at 7 days
(OR, 2.31 and 1.88, respectively). At 7 days, females (OR,
0.57) and patients who received thrombolytic therapy (OR,
0.52) were less likely to have hyperthermia. Antibiotic use
was significantly associated with hyperthermia both at 24
hours and 7 days (P0.001). WBC counts were available at
24 hours only and showed a significant association with
hyperthermia at 24 hours (P0.01). The lesion volume did
not show any significant correlation with hyperthermia at 24
hours (P0.5); a borderline significant association was seen
with hyperthermia at 7 days. Because the severity of stroke
Figure 1. Kaplan-Meier survival curves for hyperthermia versus normothermia. Y-axis: survival distribution fraction.
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emerged as the strongest clinical predictor of hyperthermia,
the 24-hour NIHSS was further categorized into 3 groups: 0
to 10, 10 to 20, and 20; and OR for hyperthermia at various
time points were calculated for the prespecified time points.
The odds of hyperthermia rose with the increasing severity of
stroke at all time points (Figure 2).
Discussion
Our study demonstrates that hyperthermia is associated with
a poor outcome in patients with acute ischemic stroke. A
novel observation that emerged from this analysis is that
delayed hyperthermia is more strongly associated with poor
outcomes than that seen in the early hours after stroke, which
suggests that a wide window of opportunity is available for
prevention and management of hyperthermia or its cause(s).
Preclinical studies have provided ample evidence for the
harmful effects of elevated temperature on ischemic brain
tissue.4–7 An increase in brain temperature, before and after
the ischemic insult, has been shown to increase the total
infarct volume.16,17 Temperature elevation may have an
all-or-none response with a defined threshold beyond which
increased temperature aggravates ischemic injury.17 Hyper-
thermia leads to physiological and structural changes, includ-
ing alteration of enzyme activity and damage to cytoskeletal
proteins. Release of neurotoxic excitatory neurotransmitters
(glutamate and glycine) and production of free radicals have
also been proposed as mechanisms through which hyperther-
mia leads to tissue injury.18–22
Clinical studies have reported hyperthermia in 18% to 61%
of patients after ischemic stroke23–25; only one study reported
Table 4. Adjusted ORs in Relation to Hyperthermia (temperature >37.2°C) at 24th hour
and 7 Days
Variable Hyperthermia at 7 Days Hyperthermia at 24 Hours
OR 95% CI P Value OR 95% CI P Value
Age 1.02 1.00–1.03 0.06 0.99 0.98–0.99 0.50
Gender
Male 1.00 1.00
Female 0.57 0.38–0.85 0.01 1.58 1.28–1.95 0.001
Smoking
Nonsmoker 1.00 1.00
Current smoker 0.69 0.41–1.17 0.17 0.55 0.38–0.81 0.01
Exsmoker 0.62 0.37–1.03 0.07 1.51 1.08–2.12 0.02
Congestive heart failure
No 1.00 1.00
Yes 1.88 1.07–3.29 0.03 1.16 0.73–1.82 0.54
Atrial fibrillation
No 1.00 1.00
Yes 0.61 0.39–0.96 0.03 1.39 1.10–1.75 0.01
NIHSS at baseline 1.03 0.98–1.08 0.19 1.08 0.96–1.22 0.22
NIHSS at 24th hour
16 1.00 1.00
16 2.31 1.36–3.95 0.01 2.76 2.04–3.73 0.001
Hemispheric stroke
Right 1.00 1.00
Left 1.07 0.74–1.54 0.72 1.25 1.03–1.53 0.03
Lesion volume
0–110 mm3 1.00 1.00
110 mm3 0.48 0.24–0.96 0.04 0.80 0.45–1.42 0.44
rtPA use
No 1.00 1.00
Yes 0.52 0.29–0.95 0.03 1.21 0.96–1.54 0.11
Antibiotic use
No 1.00 1.00
Yes 3.93 2.50–6.17 0.001 1.66 1.34–2.05 0.001
WBC count
0–11 (103/mm3) NA NA NA 1.00
11 (103/mm3) 1.63 1.18–2.25 0.01
NA indicates not available.
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a low prevalence (5.3%) of hyperthermia.10 This wide varia-
tion may be partly dependent on variable times since stroke
onset and difference in definitions of hyperthermia. Our
analysis showed that 9.3% to 17.9% of patients with ischemic
stroke had temperatures exceeding 37.2°C depending on time
elapsed from baseline. The largest body of evidence to date,
evaluating the effect of hyperthermia on poststroke outcomes,
is that from a meta-analysis that included 9 studies with a
total of 3790 patients.10 Patients with both ischemic and
hemorrhagic stroke, admitted 6 to 24 hours after stroke, were
included; temperature limits for defining hyperthermia varied
from 37.4°C to 38°C. The combined OR for mortality, as
assessed by mortality during hospital stay to within 1 year
after stroke, was 1.19 for patients with hyperthermia. The
findings in our analysis are in line with those from this
meta-analysis; however, we restricted our analysis to patients
with ischemic stroke.
Previously, although small and large analysis have high-
lighted that hyperthermia is a prognostic marker for adverse
outcomes after stroke,10–13,23–27 evidence for the influence of
timing of hyperthermia in relation to outcome is not clear (see
Supplemental Table I, available at http://stroke.ahajournals.org).
Castillo et al reported higher mortality rates in patients with
hyperthermia recorded in the first 48 hours than later; also, the
relationship between high temperature and adverse outcome was
greater the earlier the increase in temperature.24 Boysen and
Christenson observed that hyperthermia in the first 8 hours after
ischemic stroke did not have any significant impact on 3-month
outcomes; however, hyperthermia at 8 hours up to 24 hours
was a predictor of poor 3-month outcomes.13 The data may
partly be influenced by the timing of measurement of tempera-
tures since stroke onset. The present analysis has extended the
time window to 7 days after stroke, and the results suggest that
delayed hyperthermia has a greater adverse association with
long-term outcomes and mortality compared with that seen in
the early period after an ischemic stroke. An interesting obser-
vation in this analysis was a lack of association between baseline
hyperthermia and clinical outcomes. This seems to suggest that
the adverse effects of hyperthermia are not purely dependent on
aggravation of ischemic injury. Why is delayed hyperthermia
more serious than that seen in the early phase? It may, in part, be
determined by the etiology underlying the increase in tempera-
tures. Although hyperthermia in the early period after stroke may
be determined by severity of stroke and an inflammatory
response to the infarcted tissue, infections may be an important
cause of the hyperthermia seen in the later stages. Another
possibility is that delayed hyperthermia may adversely impact
physiological procedures necessary for tissue healing and neural
plasticity. The fact remains intriguing and warrants further
investigation.
The etiology of hyperthermia after stroke may be deter-
mined by numerous factors. Previous studies have demon-
strated that age, stroke type, lesion topography and volume,
stroke severity, infections, and a systemic inflammatory
response (secondary to infarction) may be determinants of
higher body temperatures after stroke.25–29 Other causes of
increase in temperature after stroke include pre-existing
infection, hospital-acquired infections, and poststroke com-
plications like aspiration pneumonia and deep vein thrombo-
sis.11,30 Superimposed infections have been reported to be a
cause of hyperthermia in 40% to 70% of patients after
stroke.31 In our analysis, the severity of stroke, as determined
by NIHSS, emerged as the strongest predictor of hyperther-
mia. The baseline NIHSS did not show significant correlation
in contrast to 24-hour NIHSS. We think that the final infarct
size/volume, which is well demarcated by 24 hours, may be
the determining factor rather than the severity of presenting
symptoms (baseline NIHSS). We did not have imaging data
regarding hemorrhagic transformation or presence of hema-
toma and could not therefore analyze relationship of the same
with hyperthermia. Lesion volumes were not significantly
associated with hyperthermia at 24 hours. However, volumes
were available for a very small number of patients (10% [311
of 3058]), the time (between 24 hours and 7 days) and mode
(CT or MRI) of measurement of volumes were variable and,
therefore, reliable conclusions cannot be drawn based on
these results. Also, the degree of inflammation may not only
depend on infarct volume, but may be determined by indi-
vidual variability in the inflammatory response. Previously,
studies have reported elevation in inflammatory markers in
acute stroke.32 However, this was a retrospective analysis of
data from studies that did not measure markers of inflamma-
tion. The WBC counts were significantly correlated with
hyperthermia. The increase in WBC counts may be related to
inflammation, secondary to the infarct, or may be an indicator
of underlying infection/inflammatory state. We did not have
access to laboratory investigations (chest x-ray, urine exam-
ination) for precise evaluation of infections. Although anti-
biotic use was significantly greater in patients with hyper-
thermia, this could have been a response (to fever) rather than
a cause (infection).
An association of hyperthermia with cardiac conditions
was also seen in our analysis. Although congestive heart
failure is known to predispose to respiratory infections, the
association between atrial fibrillation and hyperthermia may
be determined by the larger infarct size in cardioembolic
strokes. Females have been reported to have more severe
strokes, and this may explain why females were more likely
to be hyperthermic at 24 hours.33 The gender association with
hyperthermia was, however, reversed at 7 days. Whether this
is an indicator of greater predisposition to infections in males
(eg, pneumonia) remains to be analyzed. As previously
Figure 2. Unadjusted OR for hyperthermia at various time points
for severity of stroke as assessed by categorized NIHSS.
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alluded to, the determinants of hyperthermia may vary with
time from ictus. In the acute phase, the stroke severity and
infarct volume may determine the inflammatory response,
and infections may be the primary determinants in the later
period.
Our analysis has some limitations. First, the data came
from several randomized, controlled trials with inherent
selection biases peculiar to each trial. Second, the method of
temperature measurement is variable among patients included
in this analysis. Our attempt was to select a cutoff for
temperature, based on method of measurement, for which we
assumed that axillary, oral or tympanic measurements would
have been performed. Most patients had axillary measure-
ments, which tends to underestimate oral and core body
temperatures; prevalence of hyperthermia therefore may have
been underestimated. Patients may have received antipyretic
medications, which would affect the temperature measure-
ments and underestimate the number of patients with hyper-
thermia. Also, the baseline temperature for patients with
missing follow-up values was significantly lower. The miss-
ing values were random and may be due to either the specific
study design or indicative of intensive monitoring in individ-
uals with higher baseline temperatures, creating a selection
bias. Although we have addressed the etiology of hyperther-
mia in our analysis, we did not have access to laboratory
investigations needed to reliably evaluate infection as an
etiology of hyperthermia. Respiratory and urinary infections
are especially common in the early days after stroke and, after
adjustment for other prognostic factors, themselves have a
significant association with poor outcome.34 Although we
adjusted for other prognostic factors, we did not adjust for
infection rates. Of course, the diagnosis of infection is
sometimes based largely on pyrexia in the absence of focal
symptoms or signs and so some confounding is possible. We
cannot distinguish between a causal association and an
incidental association between hyperthermia and outcome;
however, some of the causes of hyperthermia can be tackled
directly, and secondary hyperthermia can also be treated.
Both offer scope for intervention during a period when
patients are under close hospital observation.
In conclusion, hyperthermia is associated with poor long-
term outcomes after ischemic stroke. This association is
stronger for delayed hyperthermia as compared with that seen
in the hyperacute phase. The adverse impact of hyperthermia,
on poststroke outcomes, does not seem to be determined
solely by aggravation of ischemic injury. The pathological
effects of hyperthermia on poststroke recovery need further
investigation. Aggressive steps to prevent and treat hyper-
thermia should be a part of management protocols for
improving clinical outcomes after ischemic stroke. The
severity of stroke and inflammation are determinants of
hyperthermia after ischemic stroke. Further research is
required for understanding the etiology of hyperthermia in
relation to time and time-dependent effects of hyperther-
mia on clinical outcomes.
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